JAMA Network
What The Study Did: Researchers evaluated whether systemic anticancer treatments, tumor subtypes, patient demographic characteristics and comorbidities were associated with COVID-19 mortality among 2,500 adult patients with cancer and COVID-19.
Authors: Gary Middleton, M.D., of the University of Birmingham in Birmingham, United Kingdom, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.0130)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
